These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15867186)

  • 1. Controversies in antiplatelet therapy for patients with cardiovascular disease.
    Bates ER; Lau WC
    Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186
    [No Abstract]   [Full Text] [Related]  

  • 2. Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested.
    Serebruany VL; Steinhubl SR; Hennekens CH
    Circulation; 2003 Apr; 107(12):1568-9. PubMed ID: 12668486
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors].
    Altin T; Kiliçkap M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 9. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acetylsalicylic acid resistance--clinical diagnosis with unclear mechanism].
    Hillarp A
    Lakartidningen; 2004 Nov; 101(45):3504-6, 3508-9. PubMed ID: 15575422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions between ACE-inhibitors and aspirin].
    Urbinati S
    Ital Heart J Suppl; 2000 Dec; 1(12):1639-40. PubMed ID: 11221592
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level.
    Vasilieva E; Kasyanova O; Shpektor A
    Acute Card Care; 2008; 10(3):181-4. PubMed ID: 18608041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and acquired determinants of individual variability of response to antiplatelet drugs.
    Schafer AI
    Circulation; 2003 Aug; 108(8):910-1. PubMed ID: 12939239
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined.
    Massie BM; Teerlink JR
    Am J Med; 2000 Oct; 109(5):431-3. PubMed ID: 11020401
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin resistance: myth or major problem?
    Grove EL; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(4):257-9. PubMed ID: 18612918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.